Venoruton as a radioprotector: a haematological assessment.
Efficacy of Venoruton--O-(hydroxyethyl) Rutoside--as a radioprotector has been tested on haematological profile of rats which were subjected to whole body radiation (500 rads). The results show radiation induced lesions in respect of total (TLC) and differential leukocyte counts (DLC)/and haemoglobin are significantly lessened when Venoruton was administered prior to radiation exposure.
Kanwar
K C
KC
Department of Biophysics, Panjab University, Chandigarh, India.
Shukla
V K
VK
Verma
A
A
D000818:Animals; D006896:Hydroxyethylrutoside / Q000031:analogs & derivatives* / Q000627:therapeutic use; D008297:Male; D011833:Radiation Injuries, Experimental / Q000517:prevention & control; D011837:Radiation-Protective Agents / Q000627:therapeutic use*; D051381:Rats
D006896:Hydroxyethylrutoside; D011837:Radiation-Protective Agents; C005865:troxerutin